We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+10.71%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$416M
AUM Growth
+$41.2M
Cap. Flow
+$4.7M
Cap. Flow %
1.13%
Top 10 Hldgs %
39.12%
Holding
82
New
2
Increased
36
Reduced
23
Closed
8

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$1.71M
2
APTV icon
Aptiv
APTV
+$1.34M
3
NKE icon
Nike
NKE
+$1.23M
4
TJX icon
TJX Companies
TJX
+$990K
5
AMZN icon
Amazon
AMZN
+$989K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$2.27M
2
CB icon
Chubb
CB
+$1.94M
3
INTC icon
Intel
INTC
+$858K
4
CSCO icon
Cisco
CSCO
+$830K
5
DHR icon
Danaher
DHR
+$658K

Sector Composition

Rank Sector Weight
1 Healthcare 21.79%
2 Technology 21.05%
3 Industrials 12.84%
4 Consumer Discretionary 8.39%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$24.2M 5.82%
136,382
-2,377
-2% -$376K
DHR icon
2
Danaher
DHR
$144B
$19M 4.57%
65,184
-2,388
-4% -$658K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.23T
$19M 4.56%
130,920
+260
+0.2% +$37.4K
MSFT icon
4
Microsoft
MSFT
$2.93T
$16.5M 3.97%
49,029
-162
-0.3% -$52.5K
XLNX
5
DELISTED
Xilinx Inc
XLNX
$14.9M 3.58%
70,119
-35
-0% -$6.9K
MA icon
6
Mastercard
MA
$480B
$14.7M 3.52%
40,780
+966
+2% +$334K
PG icon
7
Procter & Gamble
PG
$349B
$13.9M 3.35%
85,239
+3,543
+4% +$526K
ADP icon
8
Automatic Data Processing
ADP
$102B
$13.9M 3.35%
56,485
+2,029
+4% +$459K
CNI icon
9
Canadian National Railway
CNI
$78.3B
$13.2M 3.18%
107,629
+2,465
+2% +$312K
ABT icon
10
Abbott
ABT
$175B
$13.2M 3.17%
93,714
+2,590
+3% +$332K
ADI icon
11
Analog Devices
ADI
$183B
$13.2M 3.17%
74,892
+1,545
+2% +$274K
ROK icon
12
Rockwell Automation
ROK
$51.4B
$12.9M 3.1%
36,976
+112
+0.3% +$37.1K
HD icon
13
Home Depot
HD
$338B
$12.3M 2.96%
29,635
+982
+3% +$374K
JNJ icon
14
Johnson & Johnson
JNJ
$609B
$11.6M 2.79%
67,778
+2,650
+4% +$434K
ATR icon
15
AptarGroup
ATR
$8.46B
$9.65M 2.32%
78,831
+4,935
+7% +$614K
FISV
16
Fiserv Inc
FISV
$27B
$8.71M 2.1%
83,970
+6,215
+8% +$643K
RTX icon
17
RTX Corp
RTX
$261B
$8.71M 2.1%
101,236
+7,397
+8% +$645K
PYPL icon
18
PayPal
PYPL
$49.9B
$8.56M 2.06%
45,395
+1,508
+3% +$326K
NVDA icon
19
NVIDIA
NVDA
$4.91T
$8.41M 2.02%
285,970
-4,830
-2% -$133K
DIS icon
20
Walt Disney
DIS
$170B
$7.89M 1.9%
50,974
+5,193
+11% +$839K
AMZN icon
21
Amazon
AMZN
$2.66T
$7.69M 1.85%
46,140
+5,780
+14% +$989K
XYL icon
22
Xylem
XYL
$29.2B
$7.39M 1.78%
61,618
-1,150
-2% -$143K
TJX icon
23
TJX Companies
TJX
$171B
$7.01M 1.69%
92,361
+14,270
+18% +$990K
HON icon
24
Honeywell
HON
$71.3B
$6.76M 1.63%
34,411
+3,850
+13% +$777K
UNH icon
25
UnitedHealth
UNH
$387B
$6.75M 1.62%
13,434
+1,225
+10% +$555K

Similar funds

Brian C. Broderick's Q4 2021 Portfolio in Review

As of Q4 2021, Brian C. Broderick held 82 positions worth $416M, up 11% from $375M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Brian C. Broderick's Q4 2021 filing shows 2 new, 36 increased, 23 reduced and 8 closed positions. Its largest new stake was McCormick & Company Non-Voting: 3,660 shares worth $354K. The largest sale was Novartis, an estimated $2.27M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q4 2021 buy was McCormick & Company Non-Voting: 3,660 shares worth $354K.
  • Brian C. Broderick added most to Edwards Lifesciences in Q4 2021, an estimated $1.71M increase.
  • Brian C. Broderick's biggest Q4 2021 reduction was Novartis, cutting an estimated $2.27M.
  • Brian C. Broderick fully exited Chubb in Q4 2021, selling an estimated $1.94M.
  • Brian C. Broderick's ten largest holdings make up 39% of its $416M portfolio in Q4 2021.
  • Brian C. Broderick opened 2 new positions and closed 8 in Q4 2021.
  • Brian C. Broderick's portfolio value rose 11% quarter-over-quarter to $416M.

Based on Brian C. Broderick's 13F filing for Q4 2021, filed 8 Feb 2022.